Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.0%

1 terminated out of 25 trials

Success Rate

93.8%

+7.2% vs benchmark

Late-Stage Pipeline

12%

3 trials in Phase 3/4

Results Transparency

7%

1 of 15 completed with results

Key Signals

1 with results94% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (7)
P 1 (3)
P 2 (6)
P 3 (3)

Trial Status

Completed15
Recruiting5
Unknown2
Not Yet Recruiting2
Terminated1

Trial Success Rate

93.8%

Benchmark: 86.6%

Based on 15 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT07755514Not Yet RecruitingPrimary

Gabapentin and Pregabalin Effects on Inflammation and Cardiac Function in Peripheral Neuropathic Pain

NCT06834685Not ApplicableRecruiting

Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy in Cancer Patients

NCT07160049Not ApplicableCompleted

Wearable Focused Ultrasound Stimulation for Peripheral Nerve Pain Management

NCT02100046Phase 2Completed

Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain.

NCT05351801Phase 2Recruiting

Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain

NCT05890053Phase 3CompletedPrimary

To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral Neuralgia

NCT04494815Phase 1CompletedPrimary

A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419

NCT06290661Not ApplicableRecruiting

Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Peripheral Neuropathic Pain.

NCT06964243Not ApplicableRecruiting

Protocol Assessment of Motor Cortex rTMS for Treating Neuropathic Pain

NCT05817591RecruitingPrimary

Response Profiles to High-concentration Capsaicin Desensitization in Patients with Peripheral Neuropathic Pain with or Without Allodynia: a Regional Multicenter Prospective Cohort

NCT06596122Phase 2Not Yet RecruitingPrimary

Vitamin D Supplementation in Breast Cancer Patients

NCT06234917Not ApplicableCompleted

Increasing Sensori-Motor Rhythm Activity by EEG-Neurofeedback to Reduce the Impact of Pain on Daily Functioning

NCT05219812Phase 2Completed

A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain

NCT03733886Not ApplicableCompletedPrimary

Burst Spinal Cord Stimulation for Neuropathic Pain.

NCT05416931Phase 2CompletedPrimary

ACD440 Gel in Peripheral Neuropathic Pain

NCT04431778Phase 2UnknownPrimary

Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain

NCT04171453UnknownPrimary

Post-marketing Surveillance (PMS) to Observe the Safety and Effectiveness of Lyrica CR Extended Release Tablets

NCT01524796CompletedPrimary

NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions in Denmark

NCT03009500Phase 3Completed

Randomized Controlled Trial of Efficacy and Safety of Local Anesthetics and Steroids for Chronic Peripheral Post-traumatic Neuropathic Pain

NCT01293851TerminatedPrimary

Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage

Scroll to load more

Research Network

Activity Timeline